Amy Bachrodt

Executive Officer at Lycia Therapeutics.

Earliest Form D on file: Jun 2026

Filed Jun 25, 2026

Lycia Therapeutics

Extracellular protein degraders for immune diseases

Biotech, South San Francisco CA

Named, Executive Officer.

$75M

sold of $75M offered

Network

At Lycia Therapeutics

6 people

Aetna Wun Trombley
Executive Officer, Director, signed as Chief Executive Officer
Clare Ozawa
Director
Laurent Fischer
Director
Ming Fang
Director
Tim Anderson
Director
William Rieflin
Director